French pharma giant Sanofi will invest some 1 billion euros ($1.05 billion) to establish a new insulin production base in ...

Sanofi (SNY) intends to spend about $1.05B building a new insulin manufacturing base in China, Kimberley Kao of The Wall Street Journal ...

Sanofi’s latest capital outlay in China will cover the development of a new insulin plant in the nation’s capital.

Sanofi a leading global healthcare company invests ampeuro1 billion in Beijing for a new insulin plant creating jobs and bolstering China health ...

The divestiture of the Czech facility follows U.S.-based Novavax's licensing deal worth at least $1.2 billion with French ...

In 2024, domestic and foreign equity holders sold shares worth over $30 billion via block deals, showcasing sustained ...

The Chinese government's policies promoting opening up and innovation, as well as the excellent business environment it fosters for foreign enterprises, have injected strong confidence into Sanofi's ...

IGM Biosciences has pivoted from cancer therapeutics to autoimmune diseases despite setbacks, showing a 25% stock increase since last October. Click for more on IGMS.

COVID-19 vaccine maker Novavax said on Wednesday it will sell its manufacturing facility in Czech Republic to Wegovy-maker ...

Novavax sells manufacturing facility to Novo Nordisk for $200M, enabling Novavax to advance growth strategy and drive value ...

The "North America Orthobiologics Market Outlook to 2033 - Orthobiologics, Cartilage Repair and Others" report has been added to ResearchAndMarkets.com's offering.The North American orthobiologics ...